. All of the following statements about the use of spironolactone in CHF are true except
It should be administered in low doses to prevent hyperkalemial It affords prognostic benefit in severe hea failure over and above that afforded by ACE inhibitors It helps to overcome the refractoriness to thiazides It affords rapid symptomatic relief in CHF patients